Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway

BACKGROUND: Oridonin (ORI) can inhibit proliferation and migration in various types of cancer cell lines. However, the exact mechanism remains unclear. We investigated the migration inhibitory effect of ORI on human pancreatic cancer SW1990 cells and dissected the possible molecular mechanism(s). ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qian-Qian, Chen, Ke, Ye, Qiao, Jiang, Xiao-Hua, Sun, Yun-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957915/
https://www.ncbi.nlm.nih.gov/pubmed/27453691
http://dx.doi.org/10.1186/s12935-016-0336-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957915/
https://www.ncbi.nlm.nih.gov/pubmed/27453691
http://dx.doi.org/10.1186/s12935-016-0336-z

Ejemplares similares